Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (sensitising)
Additional information:

In the GPMT following the 2nd (topical) induction 7 days after the intradermal induction, severe local effects were observed which would not be expected based on the response in the primary irritation test. As such, it may be assumed that the 2nd induction already had induced an allergic reaction, which is supported by the severe skin reactions seen after the challenge application. This means that Perkalink is a strong sensitiser, with the possibility that sensitisation reactions can occur following a single induction.


Migrated from Short description of key information:
In a GPMT test Perkalink tested positive in 19/20 animals; only 1/20 controls also showed a positive reaction.

Respiratory sensitisation

Endpoint conclusion
Additional information:

See above.


Migrated from Short description of key information:
No data available; however, because of skin sensitising properties Perkalink 900 should not be inhaled.

Justification for classification or non-classification

Because of skin sensitising properties Perkalink 900 should be classified with R43 according to DSD-DPD; according to GHS-CLP this would be................